Postdoctoral Researcher at the Biomimetic Systems for Cell Engineering Research Group
Ref: PR_EM//Deadline: 29/07/2024
Ref: PR_EM//Deadline: 29/07/2024
The nanoBio&Med2024 International Conference (www.nanobiomedconf.com) will take place in-person in Barcelona (Nov 05-07, 2024). This event is going to present again the most recent international developments in the field of … Read more
A team of researchers led by the Institute for Bioengineering of Catalonia (IBEC) has developed light-activated derivatives of the anti-epileptic drug carbamazepine to treat neuropathic pain. These compounds, which show analgesic effects when activated by light, can inhibit nerve signals locally and on demand. Photopharmacological treatments offer precise action at the site of application, thus reducing systemic side effects.
Samuel Sánchez, ICREA Research Professor at the Institute for Bioengineering of Catalonia (IBEC), will lead the OrthoBots project, which focuses on the treatment of joint diseases using nanorobots. To carry out the project, Sánchez has been awarded an ERC Proof of Concept Grant, a prestigious grant from the European Research Council.
Ref: PhD-NM//Deadline: 07/08/2024
Ref: PR2-RJ // Deadline: 19/09/2024
BB_PR // Deadline: 25/07/2024